Market Place
Sourcing Support
Zydus To Start Phase III Trials Of Zintrodiazine For Malaria
26 Apr 2026 //
FIRSTWORD PHARMA
Zydus Improves ESG Rating To 68, Up From 66 Last Year
11 Apr 2026 //
INDPHARMAPOST
Zydus & Torrent Pharma Partner To Co-Market Semaglutide Injection
18 Mar 2026 //
ECONOMICTIMES
Zydus, Lupin Partner to Co-Market Semaglutide in India
17 Mar 2026 //
ECONOMICTIMES
China`s NMPA Approves Zydus-Licensed Anaemia Drug Desidustat
15 Mar 2026 //
INDPHARMAPOST
Ahead Of Its Time, A GLP-1 Drug Almost Made It Out Of India
04 Mar 2026 //
ECONOMICTIMES
Zydus, RK Pharma Strike Exclusive Deal For Novel Oncology
26 Nov 2025 //
PR NEWSWIRE
Zydus Lifesciences Posts Q2 FY26 PAT At Rs. 1,258.6 Cr
10 Nov 2025 //
INDPHARMAPOST
Indian Pharma Alliance appoints Zydus MD Sharvil Patel
04 Oct 2025 //
ECONOMICTIMES
Zydus, Pinkathon Collaborate For Breast Cancer Awareness In India
26 Sep 2025 //
EXPRESSPHARMA
Zydus Names Nitin Parekh as Special Projects President
08 Sep 2025 //
INDPHARMAPOST
Zydus Lifesciences Q1 FY26 Net Profit Hits Rs. 1,466.8 Cr
13 Aug 2025 //
INDPHARMAPOST
Health Canada Grants Zydus NOC for ZDS-Varenicline Tablets
07 Aug 2025 //
INDPHARMAPOST
Zydus Life`s profit rises on new US drug launches
20 May 2025 //
REUTERS
Zydus Lifesciences completes 25 years of listing on NSE
03 May 2025 //
INDPHARMAPOST
Zydus Lifesciences Chairman Pankaj Patel receives Padma Bhushan
30 Apr 2025 //
EXPRESSPHARMA
Zydus Lifesciences to acquire 85.6 % stake in Amplitude Surgical
26 Apr 2025 //
INDPHARMAPOST
Sentynl Therapeutics: Clinical Evidence for Nulibry in Molybdenum
04 Apr 2025 //
BUSINESSWIRE
Zynext Ventures Invests In Illexcor’s Sickle Cell Drug Development
12 Mar 2025 //
PR NEWSWIRE
Zydus Lifesciences to buy 86% stake in French medical devices maker
12 Mar 2025 //
REUTERS
Zydus Lifesciences launches ANVIMO
06 Mar 2025 //
INDPHARMAPOST
Zydus to develop combination vaccine for shigellosis and typhoid
03 Mar 2025 //
ECONOMICTIMES
Zydus Launches India`s First Flu Vaccine For 2025 South Strain
02 Mar 2025 //
EXPRESSPHARMA
Pharma sector can deliver 100 new drugs by 2047: Zydus chairman
21 Feb 2025 //
BUSINESS STD
Nifty Pharma Tanks 3% on Tariff Threat; Zydus, Lupin Down 10%
19 Feb 2025 //
BUSINESS STD
Zydus signs agreement with Synthon for 505(B)(2) oncology product
13 Feb 2025 //
EXPRESS PHARMA
Zydus Lifesciences posts Q3 FY25 net profit higher at Rs 1,024 Cr
10 Feb 2025 //
INDPHARMAPOST
Pankaj Patel Of Zydus Lifesciences Receives Padma Bhushan
27 Jan 2025 //
EXPRESSPHARMA
Zydus Adds Zituvio™, Zituvimet™ To CVS Caremark Formulary
07 Jan 2025 //
PR NEWSWIRE
Zydus eyes M&A, licensing to build its US specialty business
27 Nov 2024 //
ECONOMICTIMES
India`s Zydus Life posts Q2 profit rise on steady US demand
12 Nov 2024 //
REUTERS
Zydus Lifesciences Reports 14% Profit Rise, 22% R&D Increase
12 Nov 2024 //
FINANCIALXPRESS
Zydus Receives WHO Acceptability For ZyVac TCV For UN Purchases
23 Oct 2024 //
EXPRESSPHARMA
Zydus and ICMR Start Phase 2 Trial of Desidustat for Sickle Cell
15 Oct 2024 //
INDPHARMAPOST
High Court refuses interim injunction against Zydus cancer drug
11 Oct 2024 //
PHARMABIZ
UBS advises `selling` a bunch of pharma stocks
27 Sep 2024 //
CNBCTV
Zydus Lifesciences gets USFDA nod to market Scopolamine transdermal system
30 Aug 2024 //
ECONOMICTIMES
Zydus Lifesciences to scale up US specialties business
19 Aug 2024 //
INDIANPHARMAPOST
Zydus Lifesciences Q1 FY25 revenue up 21% YoY to reach Rs. 6,207.5 Cr
11 Aug 2024 //
INDIANPHARMAPOST
Zydus gains final USFDA approval for Valbenazine Capsules
09 Aug 2024 //
EXPRESSPHARMA
India`s Zydus Lifesciences Q1 profit beats estimates on strong US demand
08 Aug 2024 //
REUTERS
Torrent, Zydus, EQT set to make the cut for $3 bn JB Chemicals buyout
08 Aug 2024 //
ECONOMICTIMES
Zydus gets Mexican regulatory approval to market cancer treatment product
31 Jul 2024 //
ECONOMICTIMES
Zydus Lifesciences gets Mexican regulatory nod for cancer treatment biosimilar
22 Jul 2024 //
ECONOMICTIMES
Zydus signs patent licensing agreement with Takeda for `VaultA’ in India
19 Jul 2024 //
INDIANPHARMAPOST
Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug
05 Jul 2024 //
ECONOMIC TIMES
Zydus to make Biotax 1g injection available in Nepal
19 Jun 2024 //
ECONOMICTIMES
Zydus Receives Tentative USFDA Approval For Hypertension Tablets
14 Jun 2024 //
INDIANPHARMAPOST
Sentynl Therapeutics Receives Great Place To Work® Certification
03 Jun 2024 //
PR NEWSWIRE
Zydus Lifesciences net jumps to Rs. 1,182 crore in Q4, dividend at 300%
29 May 2024 //
PHARMABIZ
Zydus receives final approval from USFDA for Theophylline ER Tablets
25 May 2024 //
INDIANPHARMAPOST
Zydus announces completion of Enrolment for Phase II clinical trial of Usnoflast
25 May 2024 //
INDIANPHARMAPOST
Zydus Lifesciences gets USFDA nod for asthma treatment drug
22 May 2024 //
ECONOMICTIMES
Zydus receives final approval from USFDA for Dexamethasone Tablets
13 May 2024 //
INDINPHARMAPOST
Zydus unit acquires global rights to Eiger BioPharma’s Zokinvy
06 May 2024 //
PHARMACEUTICAL TECHNOLOGY
WHO INN approves ‘Usnoflast’ as recommended name for ZYIL1 from Zydus
01 Apr 2024 //
EXPRESS PHARMA
Zydus aims to launch first new drug in US by early 2026
27 Feb 2024 //
ECONOMIC TIMES
India`s Zydus Lifesciences beats Q3 profit estimates; approves shares buyback
09 Feb 2024 //
REUTERS
Zydus Lifesciences launches Rexigo
01 Feb 2024 //
INDIAN PHARMA POST
Zydus launches pill for prostate cancer patients
30 Jan 2024 //
ECONOMIC TIMES
